Diagnostic and Laboratory Testing in Psychiatry |
From inside the book
Results 1-5 of 19
Page 2
The Dexamethasone Suppression Test 3.1 . Clinical Correlates .... 3.2 .
Standardization and Technical Considerations 3.3 . Exclusion Criteria 3.4 .
Indications for DST 3.5 . Caution in Interpretation of the DST 4. Summary
References 39 40 40 ...
The Dexamethasone Suppression Test 3.1 . Clinical Correlates .... 3.2 .
Standardization and Technical Considerations 3.3 . Exclusion Criteria 3.4 .
Indications for DST 3.5 . Caution in Interpretation of the DST 4. Summary
References 39 40 40 ...
Page 4
... H. Rowland Pearsall , M.D. 1. Introduction .... 2. Platelets ... 2.1 . Platelet
Serotonin 2.2 . Platelet Monoamine Oxidase 3. Other Potential Trait Markers 3.1 .
Cerebrospinal Fluid Metabolites 3.2 . Plasma / Urinary MHPG and
Dexamethasone ...
... H. Rowland Pearsall , M.D. 1. Introduction .... 2. Platelets ... 2.1 . Platelet
Serotonin 2.2 . Platelet Monoamine Oxidase 3. Other Potential Trait Markers 3.1 .
Cerebrospinal Fluid Metabolites 3.2 . Plasma / Urinary MHPG and
Dexamethasone ...
Page 39
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 40
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 41
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Contents
I | 9 |
III | 9 |
IV | 9 |
V | 9 |
VI | 9 |
VII | 9 |
VIII | 9 |
IX | 10 |
CXXVII | 124 |
CXXVIII | 129 |
CXXX | 130 |
CXXXI | 131 |
CXXXIII | 132 |
CXXXIV | 134 |
CXXXV | 135 |
CXXXVI | 136 |
X | 11 |
XIII | 12 |
XVI | 13 |
XIX | 14 |
XXII | 15 |
XXVII | 16 |
XXIX | 17 |
XXX | 18 |
XXXI | 25 |
XXXIII | 26 |
XXXIV | 29 |
XXXVII | 30 |
XXXVIII | 36 |
XXXIX | 37 |
XL | 38 |
XLII | 39 |
XLIII | 40 |
XLV | 41 |
XLVI | 42 |
XLVII | 43 |
XLVIII | 45 |
L | 46 |
LI | 47 |
LIII | 48 |
LV | 49 |
LVI | 50 |
LVII | 51 |
LX | 53 |
LXII | 54 |
LXIII | 57 |
LXIV | 58 |
LXV | 59 |
LXVI | 60 |
LXVII | 61 |
LXVIII | 62 |
LXX | 63 |
LXXII | 64 |
LXXIII | 66 |
LXXV | 68 |
LXXVII | 69 |
LXXIX | 70 |
LXXXI | 71 |
LXXXII | 72 |
LXXXIII | 75 |
LXXXVI | 77 |
LXXXVII | 78 |
LXXXVIII | 79 |
LXXXIX | 80 |
XCI | 81 |
XCIII | 82 |
XCIV | 85 |
XCV | 86 |
XCVI | 87 |
XCVII | 88 |
XCIX | 90 |
CI | 91 |
CII | 92 |
CIII | 93 |
CIV | 97 |
CV | 98 |
CVI | 99 |
CVII | 101 |
CVIII | 103 |
CIX | 104 |
CX | 105 |
CXIII | 106 |
CXIV | 107 |
CXV | 108 |
CXVI | 109 |
CXVII | 110 |
CXIX | 111 |
CXX | 113 |
CXXI | 115 |
CXXII | 116 |
CXXIII | 120 |
CXXIV | 121 |
CXXV | 122 |
CXXVI | 123 |
CXXXVIII | 137 |
CXXXIX | 138 |
CXL | 139 |
CXLI | 140 |
CXLII | 141 |
CXLIII | 142 |
CXLIV | 143 |
CXLV | 144 |
CXLVI | 145 |
CXLVII | 147 |
CXLVIII | 148 |
CL | 149 |
CLI | 150 |
CLII | 153 |
CLIII | 154 |
CLIV | 155 |
CLVI | 156 |
CLVII | 157 |
CLVIII | 159 |
CLIX | 160 |
CLX | 161 |
CLXI | 162 |
CLXII | 164 |
CLXIII | 167 |
CLXIV | 169 |
CLXV | 171 |
CLXVI | 172 |
CLXVII | 174 |
CLXVIII | 177 |
CLXIX | 179 |
CLXX | 180 |
CLXXI | 183 |
CLXXII | 185 |
CLXXIV | 186 |
CLXXV | 189 |
CLXXVI | 193 |
CLXXVIII | 194 |
CLXXIX | 195 |
CLXXX | 196 |
CLXXXII | 197 |
CLXXXIII | 198 |
CLXXXV | 199 |
CLXXXVII | 200 |
CLXXXVIII | 201 |
CXC | 202 |
CXCI | 203 |
CXCIII | 204 |
CXCVI | 205 |
CXCVII | 208 |
CXCIX | 209 |
CC | 213 |
CCI | 218 |
CCII | 219 |
CCIII | 224 |
CCIV | 230 |
233 | |
CCVI | 235 |
CCVII | 237 |
CCVIII | 238 |
CCIX | 239 |
CCX | 240 |
CCXI | 242 |
CCXII | 243 |
247 | |
CCXIV | 249 |
CCXV | 250 |
CCXVI | 251 |
CCXVII | 252 |
CCXVIII | 253 |
CCXIX | 254 |
259 | |
CCXXI | 261 |
CCXXIII | 263 |
CCXXIV | 264 |
CCXXV | 266 |
CCXXVI | 267 |
269 | |
Common terms and phrases
abnormal abuse activity addition affective disorders alcohol antidepressant anxiety Arch Gen Psychiatry assessment associated behavior bipolar blood body brain cause central changes chronic Clin clinical complex concentration correlate cortisol criteria decreased deficiency dementia depressed patients detection determined dexamethasone diagnosis differential disease dose drug endogenous et al evaluation examination factors findings function glucose Gold growth half-life hormone Hospital hypothyroidism imaging important improve increased indicated laboratory lead levels lithium major depression mania measure mental metabolites MHPG mood neurological normal occur organic panic patterns physical physician plasma platelet positive possible present produce psychiatric psychosis psychotic recent relationship release reported response sample scales scan schizophrenia screen secretion seen sensitive serotonin serum severe signs specific stimulation studies substance suggested suppression symptoms syndrome Table thyroid tion treated treatment urine usually withdrawal York